NCT03112993View on ClinicalTrials.gov

Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 30, 2017

Primary Completion Date

August 13, 2018

Study Completion Date

August 14, 2018

Conditions
Spine Surgery
Interventions
DRUG

sugammadex

once at the end of the surgery

DRUG

Neostigmine

once at the end of the surgery

Trial Locations (1)

65212

University on Missouri Hospital, Columbia

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Missouri-Columbia

OTHER

NCT03112993 - Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery | Biotech Hunter | Biotech Hunter